Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-312023-04-01falseProvision of specialist medical treatment43truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13706692 2023-04-01 2024-03-31 13706692 2021-10-27 2023-03-31 13706692 2024-03-31 13706692 2023-03-31 13706692 c:Director2 2023-04-01 2024-03-31 13706692 d:MotorVehicles 2023-04-01 2024-03-31 13706692 d:MotorVehicles 2024-03-31 13706692 d:MotorVehicles 2023-03-31 13706692 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 13706692 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2023-04-01 2024-03-31 13706692 d:OfficeEquipment 2023-04-01 2024-03-31 13706692 d:OfficeEquipment 2024-03-31 13706692 d:OfficeEquipment 2023-03-31 13706692 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 13706692 d:OfficeEquipment d:LeasedAssetsHeldAsLessee 2023-04-01 2024-03-31 13706692 d:ComputerEquipment 2023-04-01 2024-03-31 13706692 d:ComputerEquipment 2024-03-31 13706692 d:ComputerEquipment 2023-03-31 13706692 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 13706692 d:ComputerEquipment d:LeasedAssetsHeldAsLessee 2023-04-01 2024-03-31 13706692 d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 13706692 d:LeasedAssetsHeldAsLessee 2023-04-01 2024-03-31 13706692 d:Goodwill 2024-03-31 13706692 d:Goodwill 2023-03-31 13706692 d:CurrentFinancialInstruments 2024-03-31 13706692 d:CurrentFinancialInstruments 2023-03-31 13706692 d:Non-currentFinancialInstruments 2024-03-31 13706692 d:Non-currentFinancialInstruments 2023-03-31 13706692 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 13706692 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 13706692 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 13706692 d:Non-currentFinancialInstruments d:AfterOneYear 2023-03-31 13706692 d:ShareCapital 2024-03-31 13706692 d:ShareCapital 2023-03-31 13706692 d:RetainedEarningsAccumulatedLosses 2024-03-31 13706692 d:RetainedEarningsAccumulatedLosses 2023-03-31 13706692 d:AcceleratedTaxDepreciationDeferredTax 2024-03-31 13706692 d:AcceleratedTaxDepreciationDeferredTax 2023-03-31 13706692 c:OrdinaryShareClass1 2023-04-01 2024-03-31 13706692 c:OrdinaryShareClass1 2024-03-31 13706692 c:OrdinaryShareClass1 2023-03-31 13706692 c:OrdinaryShareClass2 2023-04-01 2024-03-31 13706692 c:OrdinaryShareClass2 2024-03-31 13706692 c:OrdinaryShareClass2 2023-03-31 13706692 c:OrdinaryShareClass3 2023-04-01 2024-03-31 13706692 c:OrdinaryShareClass3 2024-03-31 13706692 c:OrdinaryShareClass3 2023-03-31 13706692 c:FRS102 2023-04-01 2024-03-31 13706692 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 13706692 c:FullAccounts 2023-04-01 2024-03-31 13706692 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13706692 6 2023-04-01 2024-03-31 13706692 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2024-03-31 13706692 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2023-03-31 13706692 d:Goodwill d:OwnedIntangibleAssets 2023-04-01 2024-03-31 13706692 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 13706692









WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
REGISTERED NUMBER: 13706692

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2024
2023
2023
Note
£
£
£
£

FIXED ASSETS
  

Intangible assets
 4 
227,500
257,500

Tangible assets
 5 
27,776
38,389

Investments
 6 
139,630
20,539

  
394,906
316,428

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 7 
185,341
128,576

Cash at bank and in hand
  
248,706
204,183

  
434,047
332,759

Creditors: amounts falling due within one year
 8 
(362,558)
(248,283)

NET CURRENT ASSETS
  
 
 
71,489
 
 
84,476

TOTAL ASSETS LESS CURRENT LIABILITIES
  
466,395
400,904

Creditors: amounts falling due after more than one year
 9 
(8,064)
(15,287)

PROVISIONS FOR LIABILITIES
  

Deferred tax
 10 
(6,185)
(8,660)

  
 
 
(6,185)
 
 
(8,660)

NET ASSETS
  
452,146
376,957


CAPITAL AND RESERVES
  

Called up share capital 
 11 
100
100

Profit and loss account
  
452,046
376,857

  
452,146
376,957


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

Page 1

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
REGISTERED NUMBER: 13706692
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Dr G C Martinez-Munoz
Director

Date: 14 October 2024

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


GENERAL INFORMATION

West Cambridge Anaesthetists Group Limited is a private company limited by shares and incorporated in England and Wales. Its registered office is Conqueror House, Chivers Way, Histon, Cambridge, CB24 9ZR.
The Company's functional and presentational currency is GBP.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

TURNOVER

Turnover comprises revenue recognised by the Company in respect of anaesthesia services supplied during the year, exclusive of Value Added Tax. Revenue is recognised as the fair value of the consideration received or receivable and is recognised based on the date the service is provided.

 
2.3

LEASED ASSETS: THE COMPANY AS LESSEE

Assets obtained under hire purchase contracts are capitalised as tangible fixed assets and depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to profit or loss so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Page 3

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.ACCOUNTING POLICIES (CONTINUED)

 
2.4

CURRENT AND DEFERRED TAXATION

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.5

INTANGIBLE ASSETS

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Statement of Income and Retained Earnings over its useful economic life.
All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.6

TANGIBLE FIXED ASSETS

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.ACCOUNTING POLICIES (CONTINUED)


2.6
TANGIBLE FIXED ASSETS (CONTINUED)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line or reducing balance method.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
reducing balance
Office equipment and furniture
-
25%
straight line
Computer equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

VALUATION OF INVESTMENTS

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.8

DEBTORS

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.ACCOUNTING POLICIES (CONTINUED)

 
2.11

PENSIONS

DEFINED CONTRIBUTION PENSION PLAN

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.12

DIVIDENDS

Equity dividends are recognised when they become legally payable. 


3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 4 (2023 - 3).


4.


INTANGIBLE ASSETS




Goodwill

£



COST


At 1 April 2023
300,000



At 31 March 2024

300,000



AMORTISATION


At 1 April 2023
42,500


Charge for the year on owned assets
30,000



At 31 March 2024

72,500



NET BOOK VALUE



At 31 March 2024
227,500



At 31 March 2023
257,500



Page 6

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

5.


TANGIBLE FIXED ASSETS





Motor vehicles
Office equipment and furniture
Computer equipment
Total

£
£
£
£



COST


At 1 April 2023
39,624
1,478
8,997
50,099


Additions
-
-
651
651



At 31 March 2024

39,624
1,478
9,648
50,750



DEPRECIATION


At 1 April 2023
8,255
468
2,987
11,710


Charge for the year on owned assets
-
370
3,052
3,422


Charge for the year on financed assets
7,842
-
-
7,842



At 31 March 2024

16,097
838
6,039
22,974



NET BOOK VALUE



At 31 March 2024
23,527
640
3,609
27,776



At 31 March 2023
31,369
1,010
6,010
38,389

The net book value of assets held under finance leases or hire purchase contracts, included above, are as follows:


2024
2023
£
£



Motor vehicles
23,527
31,369

Page 7

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

6.


FIXED ASSET INVESTMENTS





Listed investments
Unlisted investments
Total

£
£
£



COST OR VALUATION


At 1 April 2023
20,539
-
20,539


Additions
60,000
49,997
109,997


Revaluations
9,094
-
9,094



At 31 March 2024
89,633
49,997
139,630





7.


DEBTORS

2024
2023
£
£


Trade debtors
180,341
128,576

Other debtors
5,000
-

185,341
128,576



8.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024
2023
£
£

Trade creditors
-
1,370

Corporation tax
36,785
94,738

Other taxation and social security
1,479
873

Obligations under finance lease and hire purchase contracts
7,223
7,027

Other creditors
84,578
139,489

Accruals and deferred income
232,493
4,786

362,558
248,283


Obligations under finance lease and hire purchase contracts are secured against the assets concerned.
Other creditors include contributions of £330 (2023 - £44) payable to the Company's defined contribution pension scheme at the balance sheet date.

Page 8

 
WEST CAMBRIDGE ANAESTHETISTS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

9.


CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2024
2023
£
£

Net obligations under hire purchase contracts
8,064
15,287


Obligations under finance lease and hire purchase contracts are secured against the assets concerned.


10.


DEFERRED TAXATION




2024


£






At beginning of year
8,660


Charged to profit or loss
(2,475)



AT END OF YEAR
6,185

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
6,185
8,660


11.


SHARE CAPITAL

2024
2023
£
£
ALLOTTED, CALLED UP AND FULLY PAID



50 (2023 - 50) Ordinary A shares of £1 each
50
50
40 (2023 - 40) Ordinary B shares of £1 each
40
40
10 (2023 - 10) Ordinary C shares of £1 each
10
10

100

100


 
Page 9